The U.S. Food and Drug Administration announced approval of the Abbott Prism HIV O Plus assay, as a screening tool designed to detect the presence of certain antibodies to HIV. The assay is one of five assays that run on... (Continue reading)
Temporary cessation of antiretroviral treatment (ART) during pregnancy in women infected with HIV is an additional major risk factor for mother-to-child transmission of the virus, Italian researchers report in the May 1st issue of Clinical Infectious Diseases. “Our study,” lead investigator... (Continue reading)